{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:20:10Z","timestamp":1776835210442,"version":"3.51.2"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100015582","name":"Ovarian Cancer Academy","doi-asserted-by":"publisher","award":["W81XWH2110320"],"award-info":[{"award-number":["W81XWH2110320"]}],"id":[{"id":"10.13039\/100015582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002300","name":"Rivkin Center for Ovarian Cancer","doi-asserted-by":"publisher","award":["2021 Scientific Scholar Award"],"award-info":[{"award-number":["2021 Scientific Scholar Award"]}],"id":[{"id":"10.13039\/100002300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 CA87969"],"award-info":[{"award-number":["P01 CA87969"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Greater ovulatory years is associated with increased ovarian cancer risk. Although ovulation leads to an acute pro-inflammatory local environment, how long-term exposure to ovulation impacts ovarian carcinogenesis is not fully understood. Thus, we examined the association between gene expression profiles of ovarian tumors and lifetime ovulatory years to enhance understanding of associated biological pathways.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>RNA sequencing data was generated on 234 invasive ovarian cancer tumors that were high-grade serous, poorly differentiated, or high-grade endometrioid from the Nurses\u2019 Health Study (NHS), NHSII, and the New England Case Control Study. We used linear regression to identify differentially expressed genes by estimated ovulatory years, adjusted for birth decade and cohort, overall and stratified by menopausal status at diagnosis. We used false discovery rates (FDR) to account for multiple testing. Gene set enrichment analysis (GSEA) with Cancer Hallmarks, KEGG, and Reactome databases was used to identify biological pathways associated with ovulatory years.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>No individual genes were significantly differentially expressed by ovulatory years (FDR\u2009&gt;\u20090.19). However, GSEA identified several pathways that were significantly associated with ovulatory years, including downregulation of pathways related to inflammation and proliferation (FDR\u2009&lt;\u20091.0\u2009\u00d7\u200910<jats:sup>\u20135<\/jats:sup>). Greater ovulatory years were more strongly associated with downregulation of genes related to proliferation (e.g., E2F targets, FDR\u2009=\u20091.53\u2009\u00d7\u200910<jats:sup>\u201324<\/jats:sup>; G2M checkpoints, FDR\u2009=\u20093.50\u2009\u00d7\u200910<jats:sup>\u201322<\/jats:sup>) among premenopausal versus postmenopausal women at diagnosis. The association of greater ovulatory years with downregulation of genes involved in inflammatory response such as interferon gamma response pathways (FDR\u2009=\u20097.81\u2009\u00d7\u200910<jats:sup>\u201317<\/jats:sup>) was stronger in postmenopausal women.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results provide novel insight into the biological pathways that link ovulatory years to ovarian carcinogenesis, which may lead to development of targeted prevention strategies for ovarian cancer.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-022-00995-1","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T11:09:48Z","timestamp":1652440188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Lifetime ovulatory years and ovarian cancer gene expression profiles"],"prefix":"10.1186","volume":"15","author":[{"given":"Naoko","family":"Sasamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean J.","family":"Yoder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srikumar","family":"Chellappan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan L.","family":"Hecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke L.","family":"Fridley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn L.","family":"Terry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley S.","family":"Tworoger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,13]]},"reference":[{"issue":"9","key":"995_CR1","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1023\/A:1020678100977","volume":"13","author":"PG Moorman","year":"2002","unstructured":"Moorman PG, Schildkraut JM, Calingaert B, Halabi S, Vine MF, Berchuck A. Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States). Cancer Causes Control. 2002;13(9):807\u201311.","journal-title":"Cancer Causes Control"},{"issue":"2","key":"995_CR2","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/ijc.10927","volume":"104","author":"DM Purdie","year":"2003","unstructured":"Purdie DM, Bain CJ, Siskind V, Webb PM, Green AC. Ovulation and risk of epithelial ovarian cancer. Int J Cancer. 2003;104(2):228\u201332.","journal-title":"Int J Cancer"},{"issue":"13","key":"995_CR3","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/jnci\/89.13.932","volume":"89","author":"JM Schildkraut","year":"1997","unstructured":"Schildkraut JM, Bastos E, Berchuck A. Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer. J Natl Cancer Inst. 1997;89(13):932\u20138.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"995_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1158\/1055-9965.EPI-06-0688","volume":"16","author":"KL Terry","year":"2007","unstructured":"Terry KL, Titus-Ernstoff L, McKolanis JR, Welch WR, Finn OJ, Cramer DW. Incessant ovulation, mucin 1 immunity, and risk for ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2007;16(1):30\u20135.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"995_CR5","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1158\/0008-5472.CAN-19-2850","volume":"80","author":"B Trabert","year":"2020","unstructured":"Trabert B, Tworoger SS, O\u2019Brien KM, Townsend MK, Fortner RT, Iversen ES, et al. The risk of ovarian cancer increases with an increase in the lifetime number of ovulatory cycles: an analysis from the Ovarian Cancer Cohort Consortium (OC3). Cancer Res. 2020;80(5):1210\u20138.","journal-title":"Cancer Res"},{"issue":"7","key":"995_CR6","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/aje\/kwg177","volume":"158","author":"KH Tung","year":"2003","unstructured":"Tung KH, Goodman MT, Wu AH, McDuffie K, Wilkens LR, Kolonel LN, et al. Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study. Am J Epidemiol. 2003;158(7):629\u201338.","journal-title":"Am J Epidemiol"},{"issue":"22","key":"995_CR7","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1093\/jnci\/90.22.1729","volume":"90","author":"PM Webb","year":"1998","unstructured":"Webb PM, Green A, Cummings MC, Purdie DM, Walsh MD, Chenevix-Trench G. Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer. J Natl Cancer Inst. 1998;90(22):1729\u201334.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"995_CR8","doi-asserted-by":"publisher","first-page":"83.e1","DOI":"10.1016\/j.ajog.2006.06.088","volume":"196","author":"C Pelucchi","year":"2007","unstructured":"Pelucchi C, Galeone C, Talamini R, Bosetti C, Montella M, Negri E, et al. Lifetime ovulatory cycles and ovarian cancer risk in 2 Italian case-control studies. Am J Obstet Gynecol. 2007;196(1):83.e1\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"24","key":"995_CR9","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1200\/JCO.2016.66.8178","volume":"34","author":"N Wentzensen","year":"2016","unstructured":"Wentzensen N, Poole EM, Trabert B, White E, Arslan AA, Patel AV, et al. Ovarian cancer risk factors by histologic subtype: an analysis from the ovarian cancer cohort consortium. J Clin Oncol. 2016;34(24):2888\u201398.","journal-title":"J Clin Oncol"},{"issue":"7716","key":"995_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","volume":"2","author":"MF Fathalla","year":"1971","unstructured":"Fathalla MF. Incessant ovulation\u2013a factor in ovarian neoplasia? Lancet. 1971;2(7716):163.","journal-title":"Lancet"},{"issue":"4","key":"995_CR11","first-page":"292","volume":"5","author":"MF Fathalla","year":"2013","unstructured":"Fathalla MF. Incessant ovulation and ovarian cancer - a hypothesis re-visited. Facts Views Vis Obgyn. 2013;5(4):292\u20137.","journal-title":"Facts Views Vis Obgyn"},{"issue":"17","key":"995_CR12","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1093\/jnci\/91.17.1459","volume":"91","author":"RB Ness","year":"1999","unstructured":"Ness RB, Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst. 1999;91(17):1459\u201367.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"995_CR13","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1210\/er.2018-00075","volume":"40","author":"DM Duffy","year":"2019","unstructured":"Duffy DM, Ko C, Jo M, Brannstrom M, Curry TE. Ovulation: parallels with inflammatory processes. Endocr Rev. 2019;40(2):369\u2013416.","journal-title":"Endocr Rev"},{"issue":"5","key":"995_CR14","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/biolre\/ioz134","volume":"101","author":"LE Carter","year":"2019","unstructured":"Carter LE, Cook DP, Collins O, Gamwell LF, Dempster HA, Wong HW, et al. COX2 is induced in the ovarian epithelium during ovulatory wound repair and promotes cell survival\u2020. Biol Reprod. 2019;101(5):961\u201374.","journal-title":"Biol Reprod"},{"issue":"3","key":"995_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","volume":"34","author":"RJ Kurman","year":"2010","unstructured":"Kurman RJ, Shih I-M. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol. 2010;34(3):433\u201343.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"995_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nrc1608","volume":"5","author":"GA Colditz","year":"2005","unstructured":"Colditz GA, Hankinson SE. The nurses\u2019 health study: lifestyle and health among women. Nat Rev Cancer. 2005;5(5):388\u201396.","journal-title":"Nat Rev Cancer"},{"issue":"15","key":"995_CR17","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1093\/jnci\/90.15.1155","volume":"90","author":"B Rockhill","year":"1998","unstructured":"Rockhill B, Willett WC, Hunter DJ, Manson JE, Hankinson SE, Spiegelman D, et al. Physical activity and breast cancer risk in a cohort of young women. J Natl Cancer Inst. 1998;90(15):1155\u201360.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"995_CR18","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.ygyno.2016.09.024","volume":"143","author":"AL Shafrir","year":"2016","unstructured":"Shafrir AL, Rice MS, Gupta M, Terry KL, Rosner BA, Tamimi RM, et al. The association between reproductive and hormonal factors and ovarian cancer by estrogen-alpha and progesterone receptor status. Gynecol Oncol. 2016;143(3):628\u201335.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"995_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1158\/1055-9965.EPI-17-0609","volume":"27","author":"HR Harris","year":"2018","unstructured":"Harris HR, Rice MS, Shafrir AL, Poole EM, Gupta M, Hecht JL, et al. Lifestyle and reproductive factors and ovarian cancer risk by p53 and MAPK expression. Cancer Epidemiol Biomarkers Prev. 2018;27(1):96\u2013102.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"995_CR20","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1097\/AOG.0b013e318212fcb7","volume":"117","author":"AF Vitonis","year":"2011","unstructured":"Vitonis AF, Titus-Ernstoff L, Cramer DW. Assessing ovarian cancer risk when considering elective oophorectomy at the time of hysterectomy. Obstet Gynecol. 2011;117(5):1042\u201350.","journal-title":"Obstet Gynecol"},{"issue":"13","key":"995_CR21","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1158\/0008-5472.CAN-04-3885","volume":"65","author":"KL Terry","year":"2005","unstructured":"Terry KL, De Vivo I, Titus-Ernstoff L, Shih MC, Cramer DW. Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk. Cancer Res. 2005;65(13):5974\u201381.","journal-title":"Cancer Res"},{"issue":"12","key":"995_CR22","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1158\/1055-9965.EPI-18-0346","volume":"27","author":"ME Barnard","year":"2018","unstructured":"Barnard ME, Hecht JL, Rice MS, Gupta M, Harris HR, Eliassen AH, et al. Anti-inflammatory drug use and ovarian cancer risk by COX1\/COX2 expression and infiltration of tumor-associated macrophages. Cancer Epidemiol Biomarkers Prev. 2018;27(12):1509\u201317.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"995_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2012","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2012;29(1):15\u201321.","journal-title":"Bioinformatics"},{"issue":"2","key":"995_CR24","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2014","unstructured":"Anders S, Pyl PT, Huber W. HTSeq\u2014a python framework to work with high-throughput sequencing data. Bioinformatics. 2014;31(2):166\u20139.","journal-title":"Bioinformatics"},{"issue":"12","key":"995_CR25","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"key":"995_CR26","unstructured":"https:\/\/www.illumina.com\/content\/dam\/illumina-marketing\/documents\/products\/technotes\/evaluating-rna-quality-from-ffpe-samples-technical-note-470-2014-001.pdf."},{"issue":"43","key":"995_CR27","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham H, Averick M, Bryan J, Chang W, McGowan LDA, Fran\u00e7ois R, et al. Welcome to the Tidyverse. J Open Source Softw. 2019;4(43):1686.","journal-title":"J Open Source Softw"},{"issue":"1","key":"995_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139\u201340.","journal-title":"Bioinformatics"},{"issue":"2","key":"995_CR29","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law CW, Chen Y, Shi W, Smyth GK. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 2014;15(2):R29.","journal-title":"Genome Biol"},{"issue":"3","key":"995_CR30","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/gb-2010-11-3-r25","volume":"11","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010;11(3):R25.","journal-title":"Genome Biol"},{"issue":"7","key":"995_CR31","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"995_CR32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267\u201373.","journal-title":"Nat Genet"},{"issue":"43","key":"995_CR33","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"995_CR34","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32(18):2847\u20139.","journal-title":"Bioinformatics"},{"issue":"5","key":"995_CR35","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1530\/ERC-11-0107","volume":"18","author":"SM King","year":"2011","unstructured":"King SM, Hilliard TS, Wu LY, Jaffe RC, Fazleabas AT, Burdette JE. The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer. Endocr Relat Cancer. 2011;18(5):627\u201342.","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"995_CR36","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ygyno.2013.12.015","volume":"132","author":"K Bahar-Shany","year":"2014","unstructured":"Bahar-Shany K, Brand H, Sapoznik S, Jacob-Hirsch J, Yung Y, Korach J, et al. Exposure of fallopian tube epithelium to follicular fluid mimics carcinogenic changes in precursor lesions of serous papillary carcinoma. Gynecol Oncol. 2014;132(2):322\u20137.","journal-title":"Gynecol Oncol"},{"key":"995_CR37","doi-asserted-by":"publisher","first-page":"6116-","DOI":"10.1038\/srep06116","volume":"4","author":"Y Yang-Hartwich","year":"2014","unstructured":"Yang-Hartwich Y, Gurrea-Soteras M, Sumi N, Joo WD, Holmberg JC, Craveiro V, et al. Ovulation and extra-ovarian origin of ovarian cancer. Sci Rep. 2014;4:6116-.","journal-title":"Sci Rep"},{"issue":"7","key":"995_CR38","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1093\/aje\/kwz264","volume":"189","author":"T Huang","year":"2020","unstructured":"Huang T, Shafrir AL, Eliassen AH, Rexrode KM, Tworoger SS. Estimated number of lifetime ovulatory years and its determinants in relation to levels of circulating inflammatory biomarkers. Am J Epidemiol. 2020;189(7):660\u201370.","journal-title":"Am J Epidemiol"},{"issue":"10","key":"995_CR39","doi-asserted-by":"publisher","first-page":"9658","DOI":"10.18632\/aging.103235","volume":"12","author":"D Dai","year":"2020","unstructured":"Dai D, Chen B, Feng Y, Wang W, Jiang Y, Huang H, et al. Prognostic value of prostaglandin I2 synthase and its correlation with tumor-infiltrating immune cells in lung cancer, ovarian cancer, and gastric cancer. Aging (Albany NY). 2020;12(10):9658\u201385.","journal-title":"Aging (Albany NY)"},{"issue":"8","key":"995_CR40","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/cancers10080251","volume":"10","author":"SS Savant","year":"2018","unstructured":"Savant SS, Sriramkumar S, O\u2019Hagan HM. The role of inflammation and inflammatory mediators in the development, progression, metastasis, and chemoresistance of epithelial ovarian cancer. Cancers (Basel). 2018;10(8):251.","journal-title":"Cancers (Basel)"},{"issue":"11","key":"995_CR41","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1038\/bjc.2015.377","volume":"113","author":"J Be\u0161evi\u0107","year":"2015","unstructured":"Be\u0161evi\u0107 J, Gunter MJ, Fortner RT, Tsilidis KK, Weiderpass E, Onland-Moret NC, et al. Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study. Br J Cancer. 2015;113(11):1622\u201331.","journal-title":"Br J Cancer"},{"issue":"3","key":"995_CR42","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1525-1438.2007.01031.x","volume":"18","author":"CM Nagle","year":"2008","unstructured":"Nagle CM, Bain CJ, Green AC, Webb PM. The influence of reproductive and hormonal factors on ovarian cancer survival. Int J Gynecol Cancer. 2008;18(3):407\u201313.","journal-title":"Int J Gynecol Cancer"},{"issue":"17","key":"995_CR43","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1038\/sj.onc.1208612","volume":"24","author":"DK Dimova","year":"2005","unstructured":"Dimova DK, Dyson NJ. The E2F transcriptional network: old acquaintances with new faces. Oncogene. 2005;24(17):2810\u201326.","journal-title":"Oncogene"},{"issue":"12","key":"995_CR44","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1016\/j.biocel.2009.06.004","volume":"41","author":"Z Wu","year":"2009","unstructured":"Wu Z, Zheng S, Yu Q. The E2F family and the role of E2F1 in apoptosis. Int J Biochem Cell Biol. 2009;41(12):2389\u201397.","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"995_CR45","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.semradonc.2010.05.007","volume":"20","author":"T Udayakumar","year":"2010","unstructured":"Udayakumar T, Shareef MM, Diaz DA, Ahmed MM, Pollack A. The E2F1\/Rb and p53\/MDM2 pathways in DNA repair and apoptosis: understanding the crosstalk to develop novel strategies for prostate cancer radiotherapy. Semin Radiat Oncol. 2010;20(4):258\u201366.","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"995_CR46","first-page":"184","volume":"60","author":"M Jaiswal","year":"2000","unstructured":"Jaiswal M, LaRusso NF, Burgart LJ, Gores GJ. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res. 2000;60(1):184\u201390.","journal-title":"Cancer Res"},{"key":"995_CR47","doi-asserted-by":"publisher","first-page":"102673","DOI":"10.1016\/j.dnarep.2019.102673","volume":"83","author":"J Kay","year":"2019","unstructured":"Kay J, Thadhani E, Samson L, Engelward B. Inflammation-induced DNA damage, mutations and cancer. DNA Repair (Amst). 2019;83:102673.","journal-title":"DNA Repair (Amst)"},{"key":"995_CR48","doi-asserted-by":"publisher","first-page":"722999","DOI":"10.3389\/fonc.2021.722999","volume":"11","author":"R Chavez-Dominguez","year":"2021","unstructured":"Chavez-Dominguez R, Perez-Medina M, Aguilar-Cazares D, Galicia-Velasco M, Meneses-Flores M, Islas-Vazquez L, et al. Old and new players of inflammation and their relationship with cancer development. Front Oncol. 2021;11:722999.","journal-title":"Front Oncol"},{"issue":"3","key":"995_CR49","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1158\/1078-0432.CCR-13-2287","volume":"20","author":"KP Pennington","year":"2014","unstructured":"Pennington KP, Walsh T, Harrell MI, Lee MK, Pennil CC, Rendi MH, et al. Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas. Clin Cancer Res. 2014;20(3):764\u201375.","journal-title":"Clin Cancer Res"},{"issue":"21","key":"995_CR50","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","volume":"30","author":"K Alsop","year":"2012","unstructured":"Alsop K, Fereday S, Meldrum C, deFazio A, Emmanuel C, George J, et al. BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J Clin Oncol. 2012;30(21):2654\u201363.","journal-title":"J Clin Oncol"},{"issue":"8","key":"995_CR51","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1158\/1078-0432.CCR-18-3200","volume":"25","author":"ML Axelrod","year":"2019","unstructured":"Axelrod ML, Cook RS, Johnson DB, Balko JM. Biological consequences of MHC-II expression by tumor cells in cancer. Clin Cancer Res. 2019;25(8):2392\u2013402.","journal-title":"Clin Cancer Res"},{"issue":"23","key":"995_CR52","doi-asserted-by":"publisher","first-page":"7667","DOI":"10.1158\/1078-0432.CCR-08-0479","volume":"14","author":"MJ Callahan","year":"2008","unstructured":"Callahan MJ, Nagymanyoki Z, Bonome T, Johnson ME, Litkouhi B, Sullivan EH, et al. Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer. Clini Cancer Res. 2008;14(23):7667\u201373.","journal-title":"Clini Cancer Res"},{"issue":"1","key":"995_CR53","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/imm.12675","volume":"150","author":"E Reeves","year":"2017","unstructured":"Reeves E, James E. Antigen processing and immune regulation in the response to tumours. Immunology. 2017;150(1):16\u201324.","journal-title":"Immunology"},{"issue":"3","key":"995_CR54","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.immuni.2005.02.003","volume":"22","author":"A Corthay","year":"2005","unstructured":"Corthay A, Skovseth DK, Lundin KU, R\u00f8sj\u00f8 E, Omholt H, Hofgaard PO, et al. Primary antitumor immune response mediated by CD4+ T cells. Immunity. 2005;22(3):371\u201383.","journal-title":"Immunity"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-022-00995-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-022-00995-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-022-00995-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T12:10:05Z","timestamp":1652443805000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-022-00995-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,13]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["995"],"URL":"https:\/\/doi.org\/10.1186\/s13048-022-00995-1","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,13]]},"assertion":[{"value":"11 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nurses\u2019 Health Studies: The study protocol was approved by the institutional review boards of the Brigham and Women\u2019s Hospital and Harvard T.H. Chan School of Public Health, and those of participating registries as required.New England Case Control Study: The study was approved by the Institutional Review Board of Brigham and Women\u2019s Hospital, Boston, Massachusetts and Dartmouth College, Hanover, New Hampshire.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"S.S.T. received a grant from BMS that is unrelated to this work. The authors have no potential conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}